Kalaris Therapeutics Inc ( KLRS) - Key Metrics
KLRS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.48 | -$0.48 | -$0.48 |
| 2026Q1 | $0 | -$0.46 | -$0.56 | -$0.56 |
| 2025Q4 | $0 | -$0.44 | -$0.41 | -$0.41 |
| 2025Q3 | $0 | -$0.64 | -$0.61 | -$0.62 |
| 2025Q2 | $0 | -$0.61 | -$0.80 | -$0.80 |
KLRS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -2.12 |
| 2026Q1 | 0% | -3.14 |
| 2025Q4 | 0% | -4.80 |
| 2025Q3 | 0% | -2.26 |
| 2025Q2 | 0% | -1.09 |
KLRS
Price: $4.15
52 week price:
Earnings Per Share: -1.96 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 95.9 million